1 | less | 55,458 |
2 | 'less | 20 |
3 | clear/almost | 10 |
4 | novel-appropriate | 4 |
5 | 1=most | 3 |
6 | δalds | 3 |
7 | candidas | 2 |
8 | α-galactosidase+decellularization | 2 |
9 | γ-gliadin | 2 |
10 | -7f | 1 |
11 | 160-219/less | 1 |
12 | 17,538 | 1 |
13 | 55-74yr | 1 |
14 | abcb1_cc | 1 |
15 | adjacent-fvs | 1 |
16 | aeruginosa- | 1 |
17 | aliskiren- | 1 |
18 | better-reported | 1 |
19 | convention-rather | 1 |
20 | cyclophosphamide/pirarubicin/fluorouracil | 1 |
21 | delta-6-trans-ltb4 | 1 |
22 | diestrus-1 | 1 |
23 | edab-as | 1 |
24 | employment/training | 1 |
25 | f325l | 1 |
26 | feso₄/nafeedta | 1 |
27 | gastric-ulcer | 1 |
28 | golimumab- | 1 |
29 | gstt1-positive | 1 |
30 | heat-cycling | 1 |
31 | hig-her | 1 |
32 | higher-ki-67 | 1 |
33 | hireable | 1 |
34 | hypertenstion | 1 |
35 | improvement/stabilization/less | 1 |
36 | inactivity/under-activity | 1 |
37 | irritation/stinging | 1 |
38 | isofloridoside | 1 |
39 | less/sp | 1 |
40 | materials/lots | 1 |
41 | methods-rather | 1 |
42 | more/less | 1 |
43 | most/least | 1 |
44 | outstriper | 1 |
45 | pale/whiter | 1 |
46 | patient-friendlier | 1 |
47 | pertussis-toxoid | 1 |
48 | significantlybetter | 1 |
49 | sil-1ri | 1 |
50 | sitagliptin- | 1 |
51 | sitnf- | 1 |
52 | sulfamexazole-trimethoprim | 1 |
53 | wasmore | 1 |
54 | δtapse | 1 |
55 | less | 1 |
56 | ≤77 | 1 |
1 | 'less | 20 |
2 | -7f | 1 |
3 | 160-219/less | 1 |
4 | 17,538 | 1 |
5 | 1=most | 3 |
6 | 55-74yr | 1 |
7 | abcb1_cc | 1 |
8 | adjacent-fvs | 1 |
9 | aeruginosa- | 1 |
10 | aliskiren- | 1 |
11 | better-reported | 1 |
12 | candidas | 2 |
13 | clear/almost | 10 |
14 | convention-rather | 1 |
15 | cyclophosphamide/pirarubicin/fluorouracil | 1 |
16 | delta-6-trans-ltb4 | 1 |
17 | diestrus-1 | 1 |
18 | edab-as | 1 |
19 | employment/training | 1 |
20 | f325l | 1 |
21 | feso₄/nafeedta | 1 |
22 | gastric-ulcer | 1 |
23 | golimumab- | 1 |
24 | gstt1-positive | 1 |
25 | heat-cycling | 1 |
26 | hig-her | 1 |
27 | higher-ki-67 | 1 |
28 | hireable | 1 |
29 | hypertenstion | 1 |
30 | improvement/stabilization/less | 1 |
31 | inactivity/under-activity | 1 |
32 | irritation/stinging | 1 |
33 | isofloridoside | 1 |
34 | less | 55,458 |
35 | less/sp | 1 |
36 | materials/lots | 1 |
37 | methods-rather | 1 |
38 | more/less | 1 |
39 | most/least | 1 |
40 | novel-appropriate | 4 |
41 | outstriper | 1 |
42 | pale/whiter | 1 |
43 | patient-friendlier | 1 |
44 | pertussis-toxoid | 1 |
45 | significantlybetter | 1 |
46 | sil-1ri | 1 |
47 | sitagliptin- | 1 |
48 | sitnf- | 1 |
49 | sulfamexazole-trimethoprim | 1 |
50 | wasmore | 1 |
51 | α-galactosidase+decellularization | 2 |
52 | γ-gliadin | 2 |
53 | δalds | 3 |
54 | δtapse | 1 |
55 | less | 1 |
56 | ≤77 | 1 |
1 | aeruginosa- | 1 |
2 | golimumab- | 1 |
3 | sitnf- | 1 |
4 | aliskiren- | 1 |
5 | sitagliptin- | 1 |
6 | diestrus-1 | 1 |
7 | delta-6-trans-ltb4 | 1 |
8 | higher-ki-67 | 1 |
9 | ≤77 | 1 |
10 | 17,538 | 1 |
11 | feso₄/nafeedta | 1 |
12 | abcb1_cc | 1 |
13 | better-reported | 1 |
14 | pertussis-toxoid | 1 |
15 | isofloridoside | 1 |
16 | hireable | 1 |
17 | wasmore | 1 |
18 | δtapse | 1 |
19 | novel-appropriate | 4 |
20 | gstt1-positive | 1 |
21 | -7f | 1 |
22 | irritation/stinging | 1 |
23 | heat-cycling | 1 |
24 | employment/training | 1 |
25 | sil-1ri | 1 |
26 | f325l | 1 |
27 | cyclophosphamide/pirarubicin/fluorouracil | 1 |
28 | sulfamexazole-trimethoprim | 1 |
29 | γ-gliadin | 2 |
30 | α-galactosidase+decellularization | 2 |
31 | hypertenstion | 1 |
32 | less/sp | 1 |
33 | gastric-ulcer | 1 |
34 | hig-her | 1 |
35 | convention-rather | 1 |
36 | methods-rather | 1 |
37 | patient-friendlier | 1 |
38 | outstriper | 1 |
39 | pale/whiter | 1 |
40 | significantlybetter | 1 |
41 | 55-74yr | 1 |
42 | edab-as | 1 |
43 | candidas | 2 |
44 | δalds | 3 |
45 | less | 55,458 |
46 | 'less | 20 |
47 | 160-219/less | 1 |
48 | more/less | 1 |
49 | improvement/stabilization/less | 1 |
50 | less | 1 |
51 | materials/lots | 1 |
52 | adjacent-fvs | 1 |
53 | most/least | 1 |
54 | 1=most | 3 |
55 | clear/almost | 10 |
56 | inactivity/under-activity | 1 |